Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $253.21 million. The enterprise value is $244.78 million.
| Market Cap | 253.21M |
| Enterprise Value | 244.78M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 41.85 million shares outstanding. The number of shares has increased by 21.22% in one year.
| Shares Outstanding | 41.85M |
| Shares Change (YoY) | +21.22% |
| Shares Change (QoQ) | +7.91% |
| Owned by Insiders (%) | 8.39% |
| Owned by Institutions (%) | 33.84% |
| Float | 36.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.04 |
| Forward PS | 6.28 |
| PB Ratio | 5.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.91.
| Current Ratio | 2.10 |
| Quick Ratio | 2.04 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.77 |
Financial Efficiency
Return on equity (ROE) is -82.60% and return on invested capital (ROIC) is -61.40%.
| Return on Equity (ROE) | -82.60% |
| Return on Assets (ROA) | -35.80% |
| Return on Capital (ROIC) | -61.40% |
| Revenue Per Employee | $405,899 |
| Profits Per Employee | -$737,739 |
| Employee Count | 69 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 0.46 |
Taxes
In the past 12 months, ZVRA has paid $33,000 in taxes.
| Income Tax | 33,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.47% in the last 52 weeks. The beta is 1.96, so ZVRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | +22.47% |
| 50-Day Moving Average | 4.93 |
| 200-Day Moving Average | 5.20 |
| Relative Strength Index (RSI) | 62.19 |
| Average Volume (20 Days) | 490,934 |
Short Selling Information
The latest short interest is 2.96 million, so 7.07% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 2.76M |
| Short % of Shares Out | 7.07% |
| Short % of Float | 8.19% |
| Short Ratio (days to cover) | 13.15 |
Income Statement
In the last 12 months, ZVRA had revenue of $28.01 million and -$50.90 million in losses. Loss per share was -$1.35.
| Revenue | 28.01M |
| Gross Profit | 25.01M |
| Operating Income | -57.17M |
| Pretax Income | -50.87M |
| Net Income | -50.90M |
| EBITDA | -46.33M |
| EBIT | -48.82M |
| Loss Per Share | -$1.35 |
Balance Sheet
The company has $52.72 million in cash and $44.29 million in debt, giving a net cash position of $8.43 million or $0.20 per share.
| Cash & Cash Equivalents | 52.72M |
| Total Debt | 44.29M |
| Net Cash | 8.43M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 48.82M |
| Book Value Per Share | 1.17 |
| Working Capital | 32.98M |
Cash Flow
In the last 12 months, operating cash flow was -$45.66 million and capital expenditures -$267,000, giving a free cash flow of -$45.92 million.
| Operating Cash Flow | -45.66M |
| Capital Expenditures | -267,000 |
| Free Cash Flow | -45.92M |
| FCF Per Share | -$1.10 |
Margins
Gross margin is 89.31%, with operating and profit margins of -204.11% and -181.75%.
| Gross Margin | 89.31% |
| Operating Margin | -204.11% |
| Pretax Margin | -181.64% |
| Profit Margin | -181.75% |
| EBITDA Margin | -165.42% |
| EBIT Margin | -174.30% |
| FCF Margin | -163.97% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.22% |
| Shareholder Yield | -21.22% |
| Earnings Yield | -20.10% |
| FCF Yield | -18.14% |
Analyst Forecast
The average price target for ZVRA is $20.00, which is 230.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 230.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 60.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of -2.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.99 |
| Piotroski F-Score | 2 |